Suven Life Sciences Ltd

SUVEN
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,136 cr, stock is ranked 934
Moderate RiskStock is 2.93x as volatile as Nifty
76.002.20 (-2.81%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,136 cr, stock is ranked 934
Moderate RiskStock is 2.93x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
-9.32
PB RatioPB Ratio
10.53
Dividend YieldDiv. Yield
Sector PESector PE
31.81
Sector PBSector PB
4.71
Sector Div YldSctr Div Yld
0.89%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Suven Life Sciences Limited is a bio-pharmaceutical company, engaged in the business of manufacture and sale of bulk drugs and intermediaries.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2019202020212022312.9228.4521.2317.16-23.90-94.22-72.16-121.99
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 4.98%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Related Party Transaction 
Announced OnMay 20, 2022

Suven Life Sciences Limited has informed the Exchange about related party transaction for the period ended March 2022 | Download

Suven Life Sciences Limited has informed the Exchange about related party transaction for the period ended March 2022 | Download

Book Closure 
Announced OnMay 10, 2022

Suven Life Sciences Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 02-Aug-2022 to 04-Aug-2022 for the purpose of MT. | Download

Suven Life Sciences Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 02-Aug-2022 to 04-Aug-2022 for the purpose of MT. | Download

Cash Dividend 
Ex. DateFeb 17, 2021

Interim • Div/Share: ₹ 1

See all events